Related Experiment Video
Updated: Dec 28, 2025
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.3K
Recent highlights and advances in cardiac gene therapy
Jae Gyun Oh1, Kiyotake Ishikawa1,2
1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Discovery Medicine
|February 14, 2020
Summary
Gene therapy for heart conditions is advancing, with new approaches for monogenic disorders showing promise in animal models. Clinical trials are ongoing to establish the effectiveness of cardiac gene therapy for heart failure.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Biotechnology
Background:
- Gene therapy is rapidly progressing towards clinical applications across various medical fields.
- Cardiac gene therapy development lags behind other areas like retinal, spinal, and blood disorders.
- Monogenic cardiovascular diseases represent a key target for emerging gene therapy strategies.
Purpose of the Study:
- To review recent technological advancements in cardiac gene therapy.
- To summarize promising preclinical studies in large animal models.
- To provide an overview of current clinical trials for cardiovascular diseases.
Main Methods:
- Literature review of recent technological innovations.
- Analysis of preclinical data from large animal models.
- Survey of ongoing clinical trials in cardiac gene therapy.
Main Results:
- Significant technological progress is being made in cardiac gene therapy.
- Preclinical studies in animal models demonstrate therapeutic potential.
- Multiple clinical trials are actively investigating gene therapy for heart failure.
Conclusions:
- Cardiac gene therapy is a rapidly evolving field with increasing clinical relevance.
- Technological and preclinical advancements are paving the way for therapeutic applications.
- Ongoing clinical trials are crucial for validating gene therapy's efficacy in cardiovascular diseases.
